Saniona AB (CHIX:SANIOS) Moat Score: 0/10 (As of Jul. 04, 2026)


CHIX:SANIOS Saniona AB CHIX:SANIOS
66 GF Score
Price kr12.75
GF Value kr26.79
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Saniona AB Moat Score?

Saniona AB has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Saniona AB has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Saniona AB might have No Moat - No discernible moat.

Saniona AB  (CHIX:SANIOs) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Saniona AB Moat Score Related Terms

CHIX:SANIOS
66GF Score
Saniona AB CHIX:SANIOS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Saniona AB (CHIX:SANIOS) Overvalued in 2026?

Based on GuruFocus' analysis, Saniona AB stock appears to be undervalued. The current stock price of kr12.75 is trading 52.4% below its estimated GF Value™ of kr26.79. GuruFocus considers Saniona AB to be Significantly Undervalued.

Key valuation signals for CHIX:SANIOS:

  • Moat Score: 0
  • GF Value™: kr26.79 vs. price of kr12.75 (52.4% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the CHIX:SANIOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Saniona AB Business Description

Address Murervangen 42, Glostrup, DNK, DK-2600
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219. Geographically, it operates in USA, Sweden, Germany, Denmark, and United Kingdom, out of which it derives maximum revenue from USA.
66GF Score

Get the complete analysis for CHIX:SANIOS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.75
Price
kr26.79
GF Value